Though the condition-specific platform, as it relates to either EPA or DHA dominance, is still a “work in progress,” we do see some areas that have emerged. One such area is EPA for inflammatory conditions. EPA has a unique mechanism of action.
When addressing joint health, it is critical to not only supply proper nutrition to the tissue, but also have a long-term strategy for reducing inflammation that is effective and safe. In this article we discuss a simple two- pronged approach that can be utilized.